The Darwinian Battleground: How Cancer Treatment Rewires Healthy Human Tissue
In a groundbreaking study that challenges our fundamental understanding of how the body responds to oncology therapies, researchers from the...
In a groundbreaking study that challenges our fundamental understanding of how the body responds to oncology therapies, researchers from the...
In a move that underscores its deepening entrenchment in the global biopharmaceutical supply chain, Samsung Biologics has announced a significant...
In a significant move that underscores the ongoing evolution of biopharmaceutical manufacturing, Transcenta Therapeutics has announced a strategic licensing agreement...
In a significant leap forward for regenerative medicine and immunology, a collaborative team of researchers from Georgia Institute of Technology...
For decades, the field of neuroscience has been haunted by a fundamental limitation: the "observation gap." While the most devastating...
In a significant leap for the bioeconomy, Manus—the industry leader known as The BioAlternatives Company®—and researchers at the University of...
As the United States observes the twenty-fifth anniversary of the September 11, 2001, terrorist attacks, the national conversation has shifted...
In the ongoing quest to unravel the biological mysteries of aging, researchers have long focused on the “zombie-like” persistence of...
In the complex landscape of oncology, few breakthroughs have been as transformative as immunotherapy. By leveraging the body’s own immune...
The United States, a nation that officially declared measles eliminated in 2000, is currently grappling with a public health crisis...
In a significant stride toward revolutionizing cancer treatment, researchers at Kobe University have successfully engineered "off-the-shelf," mass-producible gamma-delta ($gammadelta$) T...
By the year 2050, the United Nations projects that the global population will necessitate a 60 percent increase in food...